Synergy CHC Corp. (SNYR) Financial Statements (2026 and earlier)

Company Profile

Business Address 865 SPRING STREET
WESTBROOK, ME 04092
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
MRQ
12/31/2024
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6881,2254601,9562,5183,641
Cash and cash equivalent6881,2254601,9562,5183,641
Restricted cash and investments100     
Receivables7,3211,6754,8454,3342,1953,980
Inventory, net of allowances, customer advances and progress billings1,7171,8612,6702,8421,103687
Inventory1,7171,8612,6702,8421,103687
Prepaid expense1,8601868291,1431,349422
Other undisclosed current assets4,375100136139100607
Total current assets:16,0605,0478,94010,4147,2649,337
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization  13627029325712
Intangible asset, including goodwill, after accumulated amortization283810,80113,32512,93917,412
Goodwill   7,7937,7937,79311,496
Intangible asset, excluding goodwill, after accumulated amortization28383,0085,5325,1455,915
Regulated entity, other noncurrent assets      379
Total noncurrent assets:28314411,07113,61913,19617,803
TOTAL ASSETS:16,3435,19120,01124,03320,46027,139
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,1924,6748,3974,3294,5595,032
Interest and dividends payable  14731 
Taxes payable31418095973911
Employee-related liabilities111217296276128
Accrued liabilities3,4671,5421,4591,3431,37039
Other undisclosed accounts payable and accrued liabilities1,7252,7076,5412,4471,9093,954
Deferred revenue248
Debt 7,725 28(2,487)750750
Derivative instruments and hedges, liabilities      3,096
Other liabilities      2,552
Deferred revenue and credits336 
Other undisclosed current liabilities4,2435,4651,9855,2916,8644,073
Total current liabilities:17,18410,14710,4117,13512,20915,503
Noncurrent Liabilities
Long-term debt and lease obligation7,457    5,208
Long-term debt, excluding current maturities7,457    5,208
Liabilities, other than long-term debt  2475,6297,464830 
Due to related parties2475,6297,464830 
Other undisclosed noncurrent liabilities 8,333   3141,009
Total noncurrent liabilities:15,7902475,6297,4641,1446,217
Total liabilities:32,97410,39416,04014,59913,35321,720
Equity
Equity, attributable to parent, including:(16,631)(5,203)3,9719,4337,1075,420
Common stock011111
Treasury stock, value(128)     
Common stock, share subscribed but unissued, subscriptions receivable     5668
Additional paid in capital8,40019,01918,81818,37716,40013,921
Accumulated other comprehensive income (loss)(48)11179(78)16 
Accumulated deficit(44,100)(24,235)(15,027)(8,866)(9,366)(8,570)
Other undisclosed equity, attributable to parent 19,244    0
Total equity:(16,631)(5,203)3,9719,4337,1075,420
TOTAL LIABILITIES AND EQUITY:16,3435,19120,01124,03320,46027,139

Income Statement (P&L) ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues34,83429,35833,82435,59634,84013,456
Gain on disposition of assets for financial service operations 30,000  
Cost of revenue(11,191)(9,138)(12,474)(9,818)(10,205)(5,308)
Cost of product and service sold(11,191)(9,138)(12,474)(9,818)(10,205)(5,308)
Gross profit:23,64320,22021,35025,77824,6358,148
Operating expenses(17,842)(28,176)(26,268)(23,955)(21,701)(7,662)
Operating income (loss):5,801(7,956)(4,918)1,8222,934486
Nonoperating income (expense)(3,574)1,1201,4918862,7997,687
Other nonoperating income   1,4911,0072,7857,633
Interest and debt expense(4,105)(131)(1,133)1,044657959
Income (loss) from continuing operations before equity method investments, income taxes:(1,878)(6,967)(4,560)3,7536,3909,132
Other undisclosed income (loss) from continuing operations before income taxes4,105(2,109)(1,849)(2,937)(6,241)(16,279)
Income (loss) from continuing operations before income taxes:2,227(9,076)(6,408)816148(7,147)
Income tax expense (benefit)(102)132248(316)(944)(390)
Income (loss) from continuing operations:2,125(8,944)(6,161)500(796)(7,537)
Income (loss) before gain (loss) on sale of properties:(8,944)(6,161)500(796)(7,537)
Net income (loss):2,125(8,944)(6,161)500(796)(7,537)
Other undisclosed net loss attributable to parent  (263)    
Net income (loss) available to common stockholders, diluted:2,125(9,207)(6,161)500(796)(7,537)

Comprehensive Income ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):2,125(8,944)(6,161)500(796)(7,537)
Other comprehensive income (loss)55     
Comprehensive income (loss):2,180(8,944)(6,161)500(796)(7,537)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (431)257(94)16 
Comprehensive income (loss), net of tax, attributable to parent:2,180(9,375)(5,904)406(780)(7,537)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: